Anticancer activity of the iron facilitator LS081

Citations of this article
Mendeley users who have this article in their library.


Cancer cells have increased levels of transferrin receptor and lower levels of ferritin, an iron deficient phenotype that has led to the use of iron chelators to further deplete cells of iron and limit cancer cell growth. As cancer cells also have increased reactive oxygen species (ROS) we hypothesized that a contrarian approach of enhancing iron entry would allow for further increased generation of ROS causing oxidative damage and cell death.




Li, Z., Tanaka, H., Galiano, F., & Glass, J. (2011). Anticancer activity of the iron facilitator LS081. Journal of Experimental and Clinical Cancer Research, 30(1).

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free